Impact of Scaling up Mass Testing, Treatment and Tracking on Malaria Prevalence Among Children
Malaria, Malaria, Asymptomatic Parasitaemia
About this trial
This is an interventional screening trial for Malaria focused on measuring Impact, mass testing, treatment, tracking, Malaria prevalence, Children, Pakro Ghana
Eligibility Criteria
Inclusion Criteria:
Overall inclusion criteria for MTTT:
- Be aged 2 months or older
- Be resident in the study area
- Have completed and signed the consent for adults or assent form for children 12-17 years.
Inclusion Criteria for children in the cohort study:
- Be age range 6 months to 14 years
- Be resident in the study area for the period of the study.
- Be willing to participate
- Parent or guardian have completed and signed consent form
Exclusion Criteria:
- If an individual intents to stay less than one year in the study site
- Be absent at some time because he/she is schooling in a boarding school
- Has a life threatening illness (excluding malaria).
Sites / Locations
- Noguchi Memorial Institute for Medical Research
Arms of the Study
Arm 1
Other
Intervention Communities
All participants confirmed using rapid diagnostic test (RDTs) to be carrying the malaria parasite will be treated using artemisinin combination therapy (ACT) following the Ghana National Malaria Treatment Guidelines and followed up on days 1, 2, 3 during treatment as DOTs (Directly observed therapy) and on day 7 post treatment. The research team together with Community volunteers will be provided the treatment guidelines which specify the dosage for each treatment regimen. Participants who receive the treatment will be observed for five minutes to ensure that they retain the drug. Those who vomit within this period will have the treatment repeated.